Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Pediatrics/Neonatology
Disease Category: Vaccines
Trial Information
A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults
A Phase I, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults
Patient Inclusion Criteria:
- Men and women > or = to 18 years of age who are scheduled to receive an autologous or allogeneic hematopoietic cell transplant within 60 days of enrollment
- HIV-infected patients with a baseline CD4 cell count < or = to 200 cells/mm^3
- Patients with hematologic malignancies, or patients who are receiving chemotherapy for breast, colorectal, lung, or ovarian malignancies
Patient Exclusion Criteria:
- History of allergy to any vaccine component; prior history of HZ
- Prior history of receipt of any varicella or zoster vaccine
Kelly Colucci, Manager, Grants and Contracts
Atlantic Health System
475 South Street
Morristown, NJ 07962
Phone: 973-660-3139
EMail: kelly.colucci@atlantichealth.org
View Google Map
Research Center Information: Atlantic Health System
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
